The Investor Capital Expo, presented by the Keiretsu Forum Mid-Atlantic and South-East, recently shone a spotlight on the tenacity and potential inherent in early-stage investments during its 11th iteration on October 25, 2023. The Philadelphia event was a vibrant confluence of innovation, attracting 200 angel investors—both in person and online. Despite recent market adjustments and a cooling of Seed and Series A funding, the expo presented an array of 12 enterprising growth-stage companies eager for investment to propel their innovative ventures forward.
The discussions at the expo were rich and forward-looking, delving into pivotal topics set by the Securities and Exchange Commission, alongside the tax, legal, and financial aspects critical for entrepreneurs and investors. With Ron Weissman, Chair of the Angel Capital Association, at the helm as keynote speaker, the gathering was reassured with insights on capital demand and the forecasted resurgence of venture capital engagement in the coming year.
Amidst the trend of rising angel member investments over the past three years, Keiretsu Forum leaders underscored the market's influence on early-stage investments. Howard Lubert, the Area President of Keiretsu Forum, emphasized the organization's commitment to nurturing robust deals and providing mentorship to companies as they strive for significant achievements and successful exits. He echoed the sentiments of industry visionaries, invoking the words of Steve Jobs to underscore the effort behind achieving rapid success.
The expo's highlight was the conferral of the Most Valued Company award, a testament to the investors' faith and recognition of excellence among participating firms. This year, Seneca Therapeutics, Inc. was the recipient of this coveted accolade. As an innovator in the biotechnology realm, Seneca Therapeutics is making significant strides in the fight against cancer with groundbreaking research that could revolutionize the treatment of solid tumors. Their commitment to developing cutting-edge oncological therapies has rightfully earned them a spot as a leader in the industry.
https://www.linkedin.com/posts/keiretsu-forum-south-east_seneca-therapeutics-jim-hussey-ceo-activity-7123276286893940736-fZ_b/